Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Alopecia areata involves immune response and gene changes affecting hair loss.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Latanoprost may cause scalp inflammation and delayed healing.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Fat injections in the face can cause hair loss.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.